v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Revenues:    
Total revenues $ 51,837,000 $ 39,603,000
Costs and operating expenses:    
Cost of goods sold 1,692,000 1,206,000
Research and development 14,956,000 15,078,000
Selling, general and administrative 35,425,000 40,023,000
Restructuring charges (394,000) 0
Total costs and operating expenses 51,679,000 56,307,000
Income (loss) from operations 158,000 (16,704,000)
Interest income 3,421,000 5,152,000
Interest expense (7,147,000) (8,200,000)
Other income (expense), net (74,000) (83,000)
Net loss $ (3,642,000) $ (19,835,000)
Basic net loss per share (in dollars per share) $ (0.01) $ (0.03)
Diluted net loss per share (in dollars per share) $ (0.01) $ (0.03)
Weighted-average shares used in calculating basic net loss per share (in shares) 669,375 665,905
Weighted-average shares used in calculating diluted net loss per share (in shares) 669,375 665,905
Product revenue, net    
Revenues:    
Total revenues $ 51,771,000 $ 39,436,000
Royalties    
Revenues:    
Total revenues $ 66,000 $ 167,000